No products in the cart.
2 Minute Medicine Rewind October 16, 2017
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia In 2014, two candidate Ebola virus (EBOV) vaccines ...
Tag: ebola
Recombinant vesicular stomatitis virus vaccine elicits anti-Ebola seroconversion
1. By day 28, all recipients of a recombinant vesicular stomatitis virus (rVSV) vaccine, at each of the three doses ...
2 Minute Medicine Rewind October 17, 2016
A population-based study of cardiovascular mortality following early-stage breast cancer The disease-specific survival for women treated for early-stage breast cancer ...
Modified vaccinia Ankara booster increases immunogenic response in Ebola Virus disease
1. Chimpanzee adenovirus 3 (ChAd3) vaccination boosted with modified vaccinia Ankara (MVA) elicited superior B- and T-cell immune responses to ...
Recombinant vesicular stomatitis virus Ebola vaccine demonstrates immunogenicity
1. Zaire ebolavirus-glycoprotein-specific antibody responses were detected in all participants receiving vaccination doses from 300,000 to 50 million plaque-forming units ...
Artesunate-amodiaquine therapy linked to lower Ebola mortality
1. Artesunate-amodiaquine (AA) treated Ebola patients had a significantly lower risk of death than artemether-lumefantrine (AL) treated patients. 2. ...
Convalescent plasma transfusions may not be effective in Ebola
1. Patients with Ebola virus disease (EVD) who received convalescent plasma transfusions had a 7% less risk of mortality ...
Vaccine protects macaques from the West African Ebola virus [PreClinical]
1. An Ebola vaccine candidate (VSV-EBOV) conferred protection from the 2014/15 West African Ebola virus strain (EBOV-Makona) in macaques when ...
rVSV-ZEBOV Ebola vaccine highly effective and safe in trials conducted in Guinea
1. Interim results from an open-label cluster-randomized trial of the novel rVSV-ZEBOV Ebola virus vaccine showed 100% vaccine efficacy in ...
Ebola virus rapid diagnostic test kit shows promise in point-of-care testing
1. The ReEBOV Antigen Rapid Test kit, which detects the Ebola virus VP40 matrix protein antigen, had 100% specificity and ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.